Maj Invest Equity
Investor profile
Venture capital
Maj Invest Equity has backed 3 European tech companies across 3 funding rounds between 2023 and 2026, joining rounds totalling €169M. Most active in Deeptech and Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2023–2026
4 yrs
Total round €
€169M
sum of rounds joined
Deals by year
distinct rounds / yearMaj Invest Equity — deals by year — interactive chart.
Data table
| Maj Invest Equity — deals by year | |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by dealsMaj Invest Equity — top sectors — interactive chart.
Data table
| Maj Invest Equity — top sectors | |
|---|---|
| Deeptech | 1 |
| Healthtech | 1 |
| Cybersecurity | 1 |
Stages
by dealsMaj Invest Equity — stages — interactive chart.
Data table
| Maj Invest Equity — stages | |
|---|---|
| Other | 1 |
| Series A | 1 |
| Series B | 1 |
Countries
by dealsMaj Invest Equity — countries — interactive chart.
Data table
| Maj Invest Equity — countries | |
|---|---|
| Denmark | 2 |
| Ukraine | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Subra | Denmark | 1 | €40M |
| Dropla Tech | Ukraine | 1 | €2.4M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Subra | Series A | €40M | 2026-04 |
| Dropla Tech | Other | €2.4M | 2025-08 |